Juvenile Primary Fibromyalgia Syndrome Clinical Trial
Official title:
Juvenile Primary Fibromyalgia in a Female Adolescent Psychiatric Population
Verified date | January 2018 |
Source | University of Kentucky |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study was to identify clinical characteristics and estimate the prevalence of Juvenile Primary Fibromyalgia in a female inpatient psychiatric population. The secondary purpose of this study was to determine the efficacy of an intervention (psychoeducational seminar and relaxation technique) on reducing the symptoms of Juvenile Primary Fibromyalgia Syndrome. We looked at the short-term and long-term effects of this intervention in comparison to the control (skin care seminar).
Status | Completed |
Enrollment | 132 |
Est. completion date | December 2008 |
Est. primary completion date | June 2008 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 12 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Admitted to inpatient child psychiatric facility - Between 12-18 years of age - in parental or family (relative as guardian) custody Exclusion Criteria: - In state custody - low intellectual functioning (i.e. IQ less than or equal to 70) - active psychosis |
Country | Name | City | State |
---|---|---|---|
United States | University of Kentucky | Lexington | Kentucky |
Lead Sponsor | Collaborator |
---|---|
Joel Thompson |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To characterize adolescents who are admitted to an inpatient psychiatric unit and meet criteria for JPFS | |||
Secondary | To determine the efficacy of an intervention on functioning and well-being (short-term and long-term) | Immediately after intervention and 8 weeks after discharge |